INS and type 2 diabetes mellitus: Despite the fact that insulin is the oldest available treatment, and still an important treatment option for type 2 diabetes, there are very few large-scale randomized trials comparing insulin with other treatments, which have an appropriate duration for an assessment of cancer risk.